Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Flowers

Showing results (191-200 of 202) with videos related to

Pageof 21
Sort By:
Nature Communications|December 21, 2022
Huntington disease oligodendrocyte maturation deficits revealed by single-nucleus RNAseq are rescued by thiamine-biotin supplementationRyan G Lim, Osama Al-Dalahmah, Jie Wu, et al.
Transplantation and Cellular Therapy|April 11, 2021
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group ReportCarrie L Kitko, Joseph Pidala, Hélène M Schoemans, et al.
Acta Neuropathologica|April 7, 2022
Wolframin is a novel regulator of tau pathology and neurodegenerationShuo Chen, Diana Acosta, Liangping Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2014
Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for LeukemiaMichael Boyiadzis, Mukta Arora, John P Klein, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 3, 2017
Survival and Late Effects after Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancy at Less than Three Years of AgeLynda M Vrooman, Heather R Millard, Ruta Brazauskas, et al.
Transplantation and Cellular Therapy|June 29, 2026
Comparison of Carmustine-, Lomustine-, and Nitrosourea-free Conditioning Regimens for Autologous Hematopoietic Cell Transplantation in Lymphoma (auto-HTC): Results from the Hematopoietic Cell Transplantation Brazilian Registry (HCTBR)Abrahão Elias Hallack Neto, Vanderson Rocha, Eliana Miranda, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 19, 2015
The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning RegimenAlvaro Urbano-Ispizua, Steven Z Pavletic, Mary E Flowers, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 24, 2017
Neurocognitive Dysfunction in Hematopoietic Cell Transplant Recipients: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Complications and Quality of Life Working Party of the European Society for Blood and Marrow TransplantationDebra Lynch Kelly, David Buchbinder, Rafael F Duarte, et al.
Bone Marrow Transplantation|January 19, 2018
Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMTDavid Buchbinder, Debra Lynch Kelly, Rafael F Duarte, et al.
Transplantation and Cellular Therapy|December 14, 2024
Allogeneic Hematopoietic Cell Transplantation in Elderly Patients in a Latin American Country: Analysis of 11 Year of Data from the Brazilian Registry SBTMO/CIBMTRFernando Barroso Duarte, Yhasmine Delles Oliveira Garcia, Nelson Hamerschlak, et al.
Pageof 21

Showing results (191-200 of 202) with videos related to

Sort By:
Pageof 21
Nature Communications|December 21, 2022
Huntington disease oligodendrocyte maturation deficits revealed by single-nucleus RNAseq are rescued by thiamine-biotin supplementationRyan G Lim, Osama Al-Dalahmah, Jie Wu, et al.
Transplantation and Cellular Therapy|April 11, 2021
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIa. The 2020 Clinical Implementation and Early Diagnosis Working Group ReportCarrie L Kitko, Joseph Pidala, Hélène M Schoemans, et al.
Acta Neuropathologica|April 7, 2022
Wolframin is a novel regulator of tau pathology and neurodegenerationShuo Chen, Diana Acosta, Liangping Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 2014
Impact of Chronic Graft-versus-Host Disease on Late Relapse and Survival on 7,489 Patients after Myeloablative Allogeneic Hematopoietic Cell Transplantation for LeukemiaMichael Boyiadzis, Mukta Arora, John P Klein, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 3, 2017
Survival and Late Effects after Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancy at Less than Three Years of AgeLynda M Vrooman, Heather R Millard, Ruta Brazauskas, et al.
Transplantation and Cellular Therapy|June 29, 2026
Comparison of Carmustine-, Lomustine-, and Nitrosourea-free Conditioning Regimens for Autologous Hematopoietic Cell Transplantation in Lymphoma (auto-HTC): Results from the Hematopoietic Cell Transplantation Brazilian Registry (HCTBR)Abrahão Elias Hallack Neto, Vanderson Rocha, Eliana Miranda, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 19, 2015
The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning RegimenAlvaro Urbano-Ispizua, Steven Z Pavletic, Mary E Flowers, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 24, 2017
Neurocognitive Dysfunction in Hematopoietic Cell Transplant Recipients: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Complications and Quality of Life Working Party of the European Society for Blood and Marrow TransplantationDebra Lynch Kelly, David Buchbinder, Rafael F Duarte, et al.
Bone Marrow Transplantation|January 19, 2018
Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMTDavid Buchbinder, Debra Lynch Kelly, Rafael F Duarte, et al.
Transplantation and Cellular Therapy|December 14, 2024
Allogeneic Hematopoietic Cell Transplantation in Elderly Patients in a Latin American Country: Analysis of 11 Year of Data from the Brazilian Registry SBTMO/CIBMTRFernando Barroso Duarte, Yhasmine Delles Oliveira Garcia, Nelson Hamerschlak, et al.
Pageof 21